Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alogliptin versus glipizide added to metformin in adults with type 2 diabetes
2008-007444-34Phase 3Completed
- Sponsor
- Takeda
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Alogliptin + metformin with Glipizide + metformin (2 arms). Primary endpoint: HbA1c change from baseline at Week 52 or 104. Started May 2009; status: completed.
02
Drugs
alogliptinglipizidemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-007444-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007444-34.